Alliancebernstein L.P. decreased its position in Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) by 3.5% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 134,614 shares of the software maker’s stock after selling 4,910 shares during the period. Alliancebernstein L.P. owned about 0.07% of Allscripts Healthcare Solutions worth $1,707,000 at the end of the most recent reporting period.
Other institutional investors have also recently made changes to their positions in the company. GSA Capital Partners LLP purchased a new position in shares of Allscripts Healthcare Solutions during the fourth quarter worth $118,000. Tudor Investment Corp Et Al increased its position in shares of Allscripts Healthcare Solutions by 36.3% in the fourth quarter. Tudor Investment Corp Et Al now owns 22,900 shares of the software maker’s stock worth $234,000 after buying an additional 6,100 shares in the last quarter. Guggenheim Capital LLC increased its position in shares of Allscripts Healthcare Solutions by 4.4% in the fourth quarter. Guggenheim Capital LLC now owns 149,708 shares of the software maker’s stock worth $1,529,000 after buying an additional 6,301 shares in the last quarter. Teachers Retirement System of The State of Kentucky increased its position in shares of Allscripts Healthcare Solutions by 11.7% in the fourth quarter. Teachers Retirement System of The State of Kentucky now owns 45,000 shares of the software maker’s stock worth $459,000 after buying an additional 4,700 shares in the last quarter. Finally, Thrivent Financial for Lutherans increased its stake in Allscripts Healthcare Solutions by 7.7% in the fourth quarter. Thrivent Financial for Lutherans now owns 31,450 shares of the software maker’s stock valued at $321,000 after buying an additional 2,260 shares during the period.
Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) traded up 0.08% during mid-day trading on Wednesday, reaching $12.33. 40,692 shares of the company were exchanged. Allscripts Healthcare Solutions, Inc. has a one year low of $9.80 and a one year high of $15.17. The stock has a 50 day moving average of $12.46 and a 200-day moving average of $12.12. The stock’s market capitalization is $2.24 billion.
Allscripts Healthcare Solutions (NASDAQ:MDRX) last issued its quarterly earnings data on Thursday, May 4th. The software maker reported $0.10 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.09 by $0.01. The firm had revenue of $415 million during the quarter, compared to the consensus estimate of $415.20 million. Allscripts Healthcare Solutions had a positive return on equity of 5.75% and a negative net margin of 2.93%. The company’s quarterly revenue was up 20.1% on a year-over-year basis. During the same period last year, the company earned $0.13 EPS. On average, equities analysts expect that Allscripts Healthcare Solutions, Inc. will post $0.62 earnings per share for the current fiscal year.
TRADEMARK VIOLATION WARNING: This report was originally published by StockNewsTimes and is owned by of StockNewsTimes. If you are viewing this report on another website, it was illegally stolen and republished in violation of US and international trademark & copyright laws. The original version of this report can be accessed at https://stocknewstimes.com/2017/08/02/allscripts-healthcare-solutions-inc-mdrx-stake-lowered-by-alliancebernstein-l-p-updated.html.
Several equities research analysts have recently commented on MDRX shares. Zacks Investment Research upgraded shares of Allscripts Healthcare Solutions from a “sell” rating to a “hold” rating in a report on Wednesday, April 19th. Leerink Swann cut shares of Allscripts Healthcare Solutions from an “outperform” rating to a “market perform” rating and cut their price target for the stock from $15.00 to $13.00 in a report on Monday, June 19th. Cantor Fitzgerald restated a “neutral” rating and set a $13.00 price target on shares of Allscripts Healthcare Solutions in a report on Monday, May 15th. Maxim Group reiterated a “buy” rating and issued a $16.00 target price on shares of Allscripts Healthcare Solutions in a research note on Monday, May 15th. Finally, BidaskClub upgraded shares of Allscripts Healthcare Solutions from a “sell” rating to a “hold” rating in a research note on Saturday, June 24th. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating and ten have issued a buy rating to the company. The stock currently has a consensus rating of “Hold” and an average price target of $14.74.
In other news, President Richard J. Poulton sold 25,000 shares of Allscripts Healthcare Solutions stock in a transaction dated Tuesday, May 16th. The stock was sold at an average price of $12.06, for a total value of $301,500.00. Following the completion of the transaction, the president now owns 412,488 shares in the company, valued at approximately $4,974,605.28. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 0.75% of the company’s stock.
Allscripts Healthcare Solutions Company Profile
Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.
Receive News & Ratings for Allscripts Healthcare Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
